Investor Relations


SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf SciClone Corporate Presentation April 2014

pdf China Regulatory and Commercialization Backgrounder

Recent Releases

Apr 1, 2014
SciClone to Present at Needham Healthcare Conference on April 8, 2014

Mar 12, 2014
SciClone Reports 2013 Financial Results and 2014 Outlook

View all releases »

Events & Presentations

Apr 8, 2014 at 5:00 PM ET
13th Annual Needham Healthcare Conference

Mar 12, 2014 at 8:30 AM ET
Q4 2013 SciClone Pharmaceuticals, Inc. Earnings

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 4.76
Change: + 0.09
Day High: 4.82
Day Low: 4.66
Volume: 150,400
Delayed at least 20 minutes.
Provided by eSignal.